Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.44 |
| ▸ | CA2 | P00918 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | RECQL | P46063 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | APEX1 | P27695 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13939462 | 0.95 | POLB (0.43) | CA1CA2MAPTKMT2ARECQL | |
| SCHEMBL7740161 | 0.89 | CA1 (0.55) | CA1CA2MAPTKMT2ARECQL | |
| SCHEMBL1764094 | 0.88 | CA1 (0.45) | CA1CA2MAPTKMT2ARECQL | |
| SCHEMBL14023026 | 0.88 | CA1 (0.45) | CA1CA2MAPTKMT2ARECQL | |
| SCHEMBL12993154 | 0.88 | KMT2A (0.38) | MAPTKMT2APOLBALDH1A1TDP1 | |
| SCHEMBL766395 | 0.87 | CA1 (0.44) | CA1CA2MAPTKMT2ARECQL | |
| SCHEMBL13964486 | 0.84 | POLB (0.41) | CA1CA2MAPTKMT2ARECQL | |
| SCHEMBL8824305 | 0.84 | POLB (0.44) | CA1CA2MAPTKMT2ARECQL | |
| SCHEMBL14022988 | 0.84 | POLB (0.44) | CA1CA2MAPTKMT2ARECQL | |
| SCHEMBL12594345 | 0.84 | KMT2A (0.44) | CA1CA2MAPTKMT2ARECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080248584-A1 | Biopolymer ionization; liquid chromatography | OXFORD GENE TECHNOLOGY IP LIMITED (GB) | 2008-10-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080248584-A1 | Biopolymer ionization; liquid chromatography | F12, F13B, F13A1 | CA1 46/4885CA2 28/4885MAPT 2903/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.